ET Now on MSN
Exclusive | Dr Reddy's USFDA 5 observations from Srikakulam plant: Details from Form 483
Dr Reddy's Laboratories informed the stock exchanges on December 12, 2025, about the conclusion of the inspection.
cGxP Lifeline conference 2025 themed ‘Defining Ethics, Elevating Quality Standards’ hosted in Mumbai
In order to usher in domestic & global regulatory compliance in pharma sector under the current revised Schedule M regime in India, cGxP Lifeline hosted its first Annual Conference 2025 in Mumbai ...
Comprehensive Ingredient Analysis and Clinical Study References Compiled as Post-Holiday Search Interest in Natural ...
Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Harbour BioMed inks long-term strategic collaboration with Lannacheng to advance next-generation radionuclide drug conjugates: Shanghai, China Tuesday, December 30, 2025, 13:00 Hr ...
A group of consumer advocate organizations has asked top health officials to take immediate action to protect the safety of ...
SEOUL, South Korea, Dec. 31, 2025 /PRNewswire/ — KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its ...
The global microreactors (flow reactors) market size was valued at US$ 0.8 Bn in 2024 and is projected to reach US$ 2.3 Bn by ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Blackstone-promoted Horizon Industrial Parks filed draft papers with SEBI to raise up to Rs. 2,600 crore via IPO, including a ...
TOMO YUME Group today announced that its subsidiary, Sparkling Sciences, a leader in exosome research and development, has successfully obtained dual certifications from the U.S. International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results